Company Filing History:
Years Active: 2019-2022
Title: Innovations of Yang Li in the Field of Medicine
Introduction
Yang Li is a notable inventor based in Gansu, China, recognized for his contributions to medical science through innovative patents. With a total of two patents to his name, he has made significant strides in the development of therapeutic solutions.
Latest Patents
Yang Li's latest patents include a fusion protein for alpha-melanocyte stimulating hormone and its preparation method and use. This fusion protein comprises a protein transduction domain (PTD), human serum albumin (HSA), and alpha-melanocyte stimulating hormone (α-MSH). The invention also details a method for preparing the fusion protein, which is aimed at inhibiting or treating central nervous system inflammations. Another significant patent involves the use of a Chinese medicine composition and Dianxianning in the preparation of a medicament for preventing or treating Alzheimer's disease. Experimental results indicate that this composition has a notable inhibiting effect on the palsy phenotype in animal models of Alzheimer's disease, suggesting its potential as a preventive or therapeutic agent.
Career Highlights
Yang Li is affiliated with Lanzhou University, where he continues to engage in research and development in the field of medicine. His work focuses on innovative approaches to treating complex health issues, particularly those affecting the central nervous system.
Collaborations
Yang Li collaborates with esteemed colleagues, including Hongyu Li and Dejuan Zhi, to further advance his research and innovations in medical science.
Conclusion
Yang Li's contributions to the field of medicine through his innovative patents highlight his commitment to addressing critical health challenges. His work not only showcases his inventive spirit but also holds promise for future advancements in therapeutic solutions.